NanoVibronix plans to price IPO of 1.5 million units at $4.95 per unit

Chardan and Maxim to sell units of one common share and one warrant

By Devika Patel

Knoxville, Tenn., July 1 – NanoVibronix, Inc. will sell 1.5 million units in its initial public offering with a 45-day greenshoe of 225,000 additional units, according to a Form S-1/A filed Tuesday with the Securities and Exchange Commission. The deal was announced on Feb. 6.

The company will sell units of one common share and one warrant at an expected price of $4.95 per unit. The warrants will be exercisable at the per-unit price for seven years.

Chardan Capital Markets, LLC and Maxim Group LLC are the joint bookrunners.

Proceeds will be used for marketing activities, clinical and regulatory activities, research and development, intellectual property protection, operations and general working capital.

The medical device company is based in Melville, N.Y. It expects its shares will trade on the Nasdaq under the symbols, “NVBX.”

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.